MENU
+Compare
NAUT
Stock ticker: NASDAQ
AS OF
Apr 2, 01:10 PM (EDT)
Price
$0.85
Change
+$0.02 (+2.41%)
Capitalization
104.72M

NAUT Nautilus Biotechnolgy Forecast, Technical & Fundamental Analysis

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome... Show more

NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for NAUT with price predictions
Apr 01, 2025

NAUT's RSI Oscillator is sitting in oversold zone for 2 days

It is expected that a price bounce should occur soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for NAUT just turned positive on March 27, 2025. Looking at past instances where NAUT's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NAUT advanced for three days, in of 241 cases, the price rose further within the following month. The odds of a continued upward trend are .

NAUT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NAUT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NAUT entered a downward trend on April 01, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.502) is normal, around the industry mean (13.458). P/E Ratio (0.000) is within average values for comparable stocks, (64.587). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.867). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (251.391).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NAUT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NAUT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NAUT is expected to report earnings to rise 4.29% to -14 cents per share on May 06

Nautilus Biotechnolgy NAUT Stock Earnings Reports
Q1'25
Est.
$-0.15
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.04
Q2'24
Beat
by $0.02
Q1'24
Beat
by $0.01
The last earnings report on February 27 showed earnings per share of -14 cents, beating the estimate of -15 cents. With 84.23K shares outstanding, the current market capitalization sits at 104.72M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2701 Eastlake Avenue East
Phone
+1 206 333-2001
Employees
167
Web
https://www.nautilus.bio
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMWAY96.311.57
+1.66%
Commonwealth Bank of Australia
SGPYY62.880.34
+0.54%
Sage Group plc (The)
FANUY13.670.04
+0.29%
Fanuc Corporation
HSTXF0.71N/A
+0.07%
Heliostar Metals Ltd.
HYSNY3.10N/A
N/A
Hysan Development Co., Ltd.

NAUT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NAUT has been loosely correlated with FHTX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if NAUT jumps, then FHTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAUT
1D Price
Change %
NAUT100%
-3.59%
FHTX - NAUT
50%
Loosely correlated
-7.53%
KYMR - NAUT
46%
Loosely correlated
-7.80%
GBIO - NAUT
43%
Loosely correlated
-9.11%
AXON - NAUT
42%
Loosely correlated
+2.90%
FATE - NAUT
42%
Loosely correlated
-4.18%
More